MADELINE HEARN
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry OPELIKA, AL NPI 1831727809
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry AL ABBVIE INC. All categories
General Payments — all program years on this page
$636.98
- Category: General Payments
- Program years: PY2021–2024
- Record count: 25
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $180.61 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $180.61 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $65.46 | 3 |
| Alkermes, Inc. | $34.18 | 2 |
| Neurocrine BioSciences, Inc. | $23.43 | 1 |
| Axsome Therapeutics, Inc. | $20.80 | 1 |
| Janssen Pharmaceuticals, Inc | $19.75 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.99 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1077908027 | Janssen Pharmaceuticals, Inc | $19.75 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103897478 | ABBVIE INC. | $21.26 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103897480 | ABBVIE INC. | $23.04 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103897482 | ABBVIE INC. | $21.16 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118907155 | Otsuka America Pharmaceutical, Inc. | $16.99 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120514170 | Alkermes, Inc. | $17.68 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120514172 | Alkermes, Inc. | $16.50 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148300158 | Axsome Therapeutics, Inc. | $20.80 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150845111 | Neurocrine Biosciences, Inc. | $23.43 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.